Increased levels of RIPK2 are linked to unfavorable outcomes in TNBC and facilitate tumor advancement through the activation of the NF-κB and JNK pathways (Jaafar et al., 2018; Singel et al., 2014). The gene discussed is RIPK2; the disease is neoplasm.